Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.
about
How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study.Elvitegravir for the treatment of HIV.Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128).Out of focus: tailoring the cascade of care to the needs of women living with HIV.Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI.Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group.Sex Differences in HIV Infection.
P2860
Q36298353-97D427B1-3D9B-4DD1-8D95-9AC1E00904C6Q38987327-A2F4E6A2-298D-4291-8CBD-1510F2AD11E5Q40048002-39D99DC9-1E50-403A-ABBC-DF2CACD5FE22Q40062892-323FF7F6-B379-469E-BDE4-825824DA15BAQ40143100-8D654892-D3F1-4C02-A43C-8C924029C1EAQ40163370-834322C1-69FD-40FF-ABE6-221FA0A7DA9CQ47560008-0FFFFD37-6A79-4CA6-A9A2-DF30A2B70336Q47572312-C83B4A19-1773-4BD1-BA0A-2BBE0E2839ADQ52674721-5F0C8C78-D47A-47D6-BDB9-C07717998125
P2860
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Integrase inhibitor versus pro ...... , double-blind, phase 3 study.
@en
type
label
Integrase inhibitor versus pro ...... , double-blind, phase 3 study.
@en
prefLabel
Integrase inhibitor versus pro ...... , double-blind, phase 3 study.
@en
P2093
P2860
P1433
P1476
Integrase inhibitor versus pro ...... , double-blind, phase 3 study.
@en
P2093
Anchalee Avihingsanon
Andrew Cheng
Cissy Kityo
Debbie Hagins
Ellen Koenig
Evgeny Voronin
Javier Szwarcberg
Kathleen Squires
Kirsten White
P2860
P304
P356
10.1016/S2352-3018(16)30016-9
P577
2016-05-27T00:00:00Z